Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2023 May 25;18(5):e0286316. doi: 10.1371/journal.pone.0286316

Microanatomical organization of hepatic venous lymphatic system in humans

Kotaro Umemura 1,2, Hiroshi Shimoda 2,3, Keinosuke Ishido 1, Norihisa Kimura 1, Taiichi Wakiya 1, Takuji Kagiya 1,2, Kentaro Sato 1,2, Yuto Mitsuhashi 1,2, Seiji Watanabe 2, Hirokazu Narita 4, Tomohiro Chiba 2, Kenichi Hakamada 1,*
Editor: Shozo Yokoyama5
PMCID: PMC10212168  PMID: 37228087

Abstract

Lymphatic fluid drains from the liver via the periportal lymphatic, hepatic venous lymphatic, and superficial lymphatic systems. We performed a postmortem study to clarify the three-dimensional structure and flow dynamics of the human hepatic venous lymphatic system, as it still remains unclear. Livers were excised whole from three human cadavers, injected with India ink, and sliced into 1-cm sections from which veins were harvested. The distribution of lymphatic vessels was observed in 5 μm sections immunostained for lymphatic and vascular markers (podoplanin and CD31, respectively) using light microscopy. Continuity and density of lymphatic vessel distribution were assessed in en-face whole-mount preparations of veins using stereomicroscopy. The structure of the external hepatic vein wall was assessed with scanning electron microscopy (SEM). The lymphatic dynamics study suggested that lymphatic fluid flows through an extravascular pathway around the central and sublobular veins. A lymphatic vessel network originates in the wall of sublobular veins, with a diameter greater than 110 μm, and the peripheral portions of hepatic veins and continues to the inferior vena cava. The density distribution of lymphatic vessels is smallest in the peripheral portion of the hepatic vein (0.03%) and increases to the proximal portion (0.22%, p = 0.012) and the main trunk (1.01%, p < 0.001), correlating positively with increasing hepatic vein diameter (Rs = 0.67, p < 0.001). We revealed the three-dimensional structure of the human hepatic venous lymphatic system. The results could improve the understanding of lymphatic physiology and liver pathology.

Introduction

The liver produces a large amount of lymphatic fluid, of which 25%–50% flows through the thoracic duct [1]. Lymphatic fluid produced from the intrahepatic portal vein and intrahepatic artery drains through three pathways: the periportal lymphatic system along the portal triad; the hepatic venous lymphatic system along the hepatic veins; and the superficial lymphatic system of the liver capsule [29]. The hepatic venous lymphatic system has been studied in several mammals [10, 11]. Ohtani et al. observed collagen fiber bundles around central and sublobular veins on electron microscopy and suggested that they might work as an extravascular fluid pathway [12]. Poonkhum et al. performed a microanatomical study of the hepatic venous lymphatic systems of cats; they ligated the thoracic duct, which led to the dilation of the sinusoids, the space of Disse, interstitial space of sublobular veins, and sublobular lymphatic vessels [10]. The presence of immune cells in these dilated areas indicated that lymphatic fluid produced in the liver enters sublobular lymphatic vessels from the space of Disse through the sublobular interstitial space [10]. Although the findings so far suggest that the hepatic venous lymphatic system involves a drainage pathway along hepatic veins, the details on its structure and function in the human liver have not been elucidated. In this study, we performed a microanatomical analysis of the human liver to reveal the three-dimensional structure and lymphatic flow dynamics of the hepatic venous lymphatic system.

Materials and methods

Study design

This was a postmortem liver study. Specimens of human liver were collected from three humans (Table 1). Donor was enrolled before his death in an association of people who offered to donate their bodies with the consent of themselves and their relatives, provided that they were not infected with human immunodeficiency virus, hepatitis B virus, or hepatitis C virus. Additionally, we obtained consent from the relatives posthumously. The study was approved by the Human Research Ethics Committee of Hirosaki University Graduate School of Medicine (reference number 2019–1075). We received opt-out consent from the relatives for this study.

Table 1. Details of the three cadavers.

No. Age Sex Cause of death Preservation time until specimen collection Pathological findings of the liver Goal of the experiment
1 75 male suffocation 22 months mild hepatitis Lymphatic distribution around hepatic veins
2 88 female cerebral hemorrhage 15 months moderate hepatitis Lymphatic dynamics around hepatic veins
3 91 female acute pneumonia 22 months almost normal The three-dimensional structure of lymphatic vessels around hepatic veins

The details of cadavers

Postmortem, 10% formalin and 5% phenol were injected through the femoral artery of the cadavers and fixed. They had no hepatic tumors or abdominal malformations. The details of the cadavers used in the experiment were shown in Table 1. The main studies on the three cadavers are as follows. Cadaver No.1: Sections across the hepatic veins and inferior vena cava were prepared and studied to clarify the lymphatic anatomy around the hepatic veins, including the sublobular vein. Cadaver No.2: To elucidate the lymph dynamics around the hepatic veins, sections were prepared from liver specimens in which Indian ink was injected into the right lobe and examined using microscope. Cadaver No.3: To clarify the three-dimensional structure and distribution of lymphatic vessels around hepatic veins, whole mount immunostaining was performed on a block of hepatic vein with the liver parenchyma removed and examined using stereomicroscope.

Specimen collection

The livers were excised whole; one of them was injected with 5 mL India ink (into the right lobe parenchyma) to investigate the flow of interstitial tissue fluid. Each liver was sectioned coronally approximately every 1 cm. Several hepatic veins were harvested from each hepatic segment. After removal of as many hepatic plates as possible, samples were embedded in paraffin and sliced to approximately 5 μm thickness for use in SEM.

Light microscopy

The 5 μm tissue sections were deparaffinized and stained with hematoxylin and eosin. They were then incubated in 0.01 M citrate buffer (pH 6.0) at 121°C for 15 min to retrieve the antigenicity of the target proteins before immunostaining. The sections were immersed in 0.3% H2O2 in PBS (1/15 M, pH 7.4) for 20 min at room temperature to block endogenous peroxidase activity. After washing with 1/12 M PBS (pH 7.4), they were incubated in 5% normal goat serum (Vector Laboratories, Burlingame, CA, USA) for 15 min, followed by incubation with a mixture of antibodies against the lymphatic marker podoplanin (D2-40, DAKO, Santa Clara, CA, USA; ×100 dilution) and the vascular marker CD31 (EP3095; ×250 dilution, Abcam, Tokyo, Japan) at 4°C overnight. Following rinsing in PBS, the sections were treated with anti-mouse IgG conjugated to alkaline phosphatase (AP; Histofine Simple Stain AP, Nichirei Biosciences, Tokyo, Japan) for 2 h at room temperature, and the immunoreaction was visualized with the AP reaction Vector Blue Substrate Kit (Vector Laboratories). They were then treated with anti-rabbit IgG conjugated to horseradish peroxidase (Histofine Simple Stain MAX-PO, Nichirei Biosciences) followed by visualization of the immunoreaction by use of diaminobenzidine (DAB; DAKO). The stained sections were examined using a BX-50 light microscope equipped with a DP72 digital imaging system (Olympus, Tokyo, Japan). The wall thickness of the sublobular vein with lymphatic vessels was measured using ImageJ software.

Stereomicroscopy of lymphatic vessel continuity and distribution

The harvested hepatic vein samples were readied for en-face whole-mount preparation by rinsing in PBS containing 3% Triton X-100 (FUJIFILM Wako Pure Chemical Corporation, Osaka, Japan) and were immersed in 5% normal goat serum (Vector Laboratories) for 2 days at 4°C, then incubated with an antibody to podoplanin (DAKO) for 14 days at 4°C while being gently shaken. After washing with PBS with Triton, immunoreaction was shown with anti-mouse IgG conjugated to AP (Nichirei Biosciences) and AP reaction medium [13]. The vessels were cut longitudinally and mounted on glass slides.

Stereomicroscopy was performed with an MVX100 stereomicroscope and recorded with the DP80 imaging system (Olympus). The hepatic veins were divided into three portions under the stereomicroscope and classified by size as follows: the main trunk (large vessels draining to the inferior vena cava), the peripheral portion (slender vessels receiving numerous sublobular veins), and the proximal portion (intermediate veins bridging between the main trunk and peripheral portions). Continuity across the different proportions was assessed.

For quantification of the lymphatic vessels, the tissues were processed with a tissue-clearing treatment using the reagents CUBIC-HL and CUBIC-R+ (Tokyo Chemical Industry, Tokyo, Japan) in accordance with the manufacturer’s protocol. The cleared tissues were viewed under a stereomicroscope and the ratio of the area positive for podoplanin to the total vein wall area was calculated after processing the images with ImageJ software. If the area of a specimen was large and required multiple images from different parts of the sample, all the images were merged in Adobe Photoshop CC (Adobe Systems, San Jose, CA, USA) before calculation of the lymphatic area. The diameter of each venous segment was also measured in the processed images and the correlation between vessel size and density of lymphatic vessel distribution was assessed. The estimated number of samples of the peripheral portion, the proximal portion, and the main trunk were 30, 29, and 14, respectively.

Scanning Electron Microscopy (SEM)

Specimens containing peripheral venous segments were processed for SEM as described previously [14] to examine the outer wall of hepatic veins in which lymphatic vessels had been observed in the adventitia. Briefly, the tissues were stained en bloc with 1% osmium tetroxide solution and 1% tannic acid for 1 h each, and then postfixed in 1% osmium solution for 1 h. They were dehydrated in a graded ethanol series, freeze-dried with t-butyl alcohol, and observed under a JEOL JSM-6510 (JEOL, Tokyo, Japan).

Schematic illustration of the hepatic venous lymphatic system

The lymphatic network around hepatic veins was illustrated as a model that was reconstructed from data obtained using light microscopy, stereomicroscopy, SEM, and statistical analysis. The schematic illustration was created with Adobe Illustrator CC (Adobe).

Statistical analysis

Comparisons of the density of lymphatic vessels in different portions of the hepatic vessels were made using the Kruskal–Wallis test. We further used the Spearman rank correlation coefficient to evaluate the associations between the diameters of the hepatic vein segments and the density distribution of lymphatic vessels. The samples of peripheral portions were excluded because there were few lymphatic vessels in many samples. Two-tailed values of p < 0.05 were regarded as significant in each analysis. All statistical analyses were performed using EZR (Saitama Medical Center, Jichi Medical University, Japan), a graphical user interface for the R software program (The R Foundation for Statistical Computing, Vienna, Austria).

Results

Lymphatic vessel locations

Lymphatic vessels were observed throughout the adventitia and intima of the inferior vena cava but were mainly in the adventitia in hepatic veins (Fig 1A and 1B). In addition, a small number of lymphatic vessels were found in the adventitia of some sublobular veins (Fig 1C) that had a wall thickness greater than 110 μm. Lymphatic vessels were not found in central veins or in sublobular veins with walls thinner than 100 μm (Fig 1D).

Fig 1. Distribution of lymphatic vessels in hepatic veins.

Fig 1

Vessels were stained for podoplanin and CD31 in 5 μm sections and were assessed by light microscopy. (A) Inferior vena cava. (B) Hepatic vein. (C) Sublobular vein. (D) Central vein. Lymphatic vessels (arrowheads) were present in the adventitia and intima of the inferior vena cava, in the adventitia of hepatic veins and in some sublobular veins that had a wall thickness greater than 110 μm. Lymphatic vessels were not observed in central veins or most other sublobular veins. Scale bars: 100 μm (A, B); 50 μm (C, D).

Lymphatic vessel continuity

Continuity was seen from lymphatic vessels in the hepatic vein peripheral portion through to the proximal portion and the main trunk into the inferior vena cava (Fig 2A–2D). Lymphatic vessels with blind ends were also seen in the peripheral portion, and no lymphatic vessels were observed in the peripheral hepatic veins. Blind ends were also observed in the proximal portion and the main trunk of hepatic veins (Fig 2B–2D).

Fig 2. Continuity and density distribution of lymphatic vessels from hepatic veins to the inferior vena cava.

Fig 2

Vessels were stained for podoplanin and CD31 and assessed as en-face whole-mount preparations by stereomicroscopy. (A) Peripheral portion: lymphatic vessels with blind ends were observed (arrowhead). (B) Proximal portion: lymphatic vessels were mainly continuous and became more abundant in the area where the hepatic veins were more centrally located. (C) Main trunk of the hepatic vein: lymphatic vessels were observed all around the wall of the main trunk. (D) Border between the inferior vena cava and the right hepatic vein: the lymphatic vessels of the main trunk of the hepatic vein were continuous with those of the inferior vena cava (the border is indicated by a perforated line), forming a rich lymphovascular network. The blind ends of lymphatic vessels were also observed in the proximal portion and the main trunk of the hepatic vein (B-D). Scale bars: 1 mm.

Distribution of lymphatic vessels in the hepatic veins

Microscopically, dense lymphatic vessels were observed in the more central part of the hepatic veins. Therefore, we examined the relationship between the diameter of hepatic veins and the density of lymphatic vessels. The ratio of lymphatic vessels to the vessel area differed significantly between the different portions of the hepatic veins (peripheral portion, 0.03%; proximal portion, 0.22%; and main trunk, 1.01%; Fig 3). We also showed that there was a direct correlation between the distribution rate of lymphatic vessels and the diameter of the hepatic vein (Fig 4), supported by more abundant lymphatic vessels in areas where hepatic veins were more centrally located (Fig 2B).

Fig 3. Distribution rate of lymphatic vessels in each portion of the hepatic vein.

Fig 3

The distribution ratio of lymphatic vessels area was defined as the ratio of the podoplanin-positive area to total vein wall area. The distribution ratio increased from the peripheral portion (0.03%) to the proximal portion (0.22%) and to the main trunk (1.01%). *p = 0.012. **p = 0.0074. ****p<0.0001. Abbreviation: LVA/VA = ratio of lymphatic vessels to total area of hepatic vein wall.

Fig 4. Correlation between density distribution of lymphatic vessels and hepatic vein diameter.

Fig 4

Correlations were calculated using proximal and main trunk portions only, as few lymphatic vessels were present in the peripheral portions. The Spearmann’s rank correlation coefficient between the diameter of the hepatic veins and the distribution rate of lymphatic vessels (LVA/VA ratio) was calculated. The distribution ratio of lymphatic vessels increased significantly as the diameter of the hepatic veins became larger. (Rs = 0.67, p<0.001). Abbreviation: LVA/VA = ratio of lymphatic vessels to total area of hepatic vein wall.

Lymphatic fluid flow around hepatic veins

We observed India ink in the perivascular space and interstitium around central veins and small sublobular veins. India ink was consistently seen in vein walls in all portions of the hepatic vein and the inferior vena cava (Fig 5A–5E). India ink was also observed around the Gleason’s sheath and diffusely around the sinusoids (Fig 5F).

Fig 5. The distribution of lymphatic vessels and India ink in the hepatic veins (Immunohistochemistry for podoplanin and CD31).

Fig 5

The uppercase letters show a magnified view of the area of the arrowhead in lowercase. a, A; central vein: India ink was observed in the perivascular space and in the interstitium of the central vein wall (arrow) b, B; sublobular vein: India ink was observed in the perivascular space and in the interstitium of the sublobular vein wall (arrow). c, C; sublobular vein with lymphatic vessel: India ink was present in the lymphatic vessels (arrowhead) of the sublobular veins. Scale bars: 50 μm (b, B), 100 μm (a, A, c, C,). d, D: hepatic vein. e, E; Vena Cava inferior. India ink was also present in the lymphatic vessels (arrowhead) of the hepatic veins and Inferior vena cava. f; Indian ink injection point: India ink injected into the liver parenchyma flowed into sinusoids and the Gleason’s sheath. Scale bars: 100 μm (d, D, e, E), 500 μm (f).

External structure of hepatic veins on SEM

In specimens where lymphatic vessels were observed, we found that the outer walls of hepatic veins were mainly composed of collagen fibrils, having a cribriform structure with small pores of about 10 μm in size (Fig 6A). In the walls of sublobular veins, we observed a meshwork structure consisting of collagen fibrils containing lymphocytes (Fig 6B and 6C).

Fig 6.

Fig 6

Discussion

Liver tumors, including metastatic liver tumors and primary liver cancer, are known to metastasize to mediastinal lymph nodes. The prognosis for patients with mediastinal lymph node metastases is extremely poor, and little is known about the pathway of metastasis [15, 16]. Therefore, clarification of intrahepatic lymphatic anatomy is needed to elucidate the pathway of metastasis. We focused on the lymphatic anatomy around the hepatic veins.

Using three different microscopic techniques, we revealed the three-dimensional structures of the hepatic venous lymphovascular networks in human livers. No lymphatic vessels are seen in the central vein or most sublobular veins. Instead, lymphatic fluid flows along an extravascular pathway in the perivascular space and interstitium. The lymphatic vessel network originates mainly in the peripheral portion of the hepatic veins where they meet many sublobular hepatic veins. Lymphatic fluid enters veins through pores in the cribriform outer walls and flows into the lymphatic vessels via blind ends. The distribution of lymphatic vessels becomes increasingly dense in the proximal portions and the main trunks of hepatic veins, creating a rich lymphovascular network in the inferior vena cava (Fig 7).

Fig 7. Schema of lymphovascular networks from the central vein to the inferior vena cava.

Fig 7

A: central vein B: sublobular vein C: peripheral portion D: proximal portion E: main trunk F: inferior vena cava. Some of the lymphatic fluid derived from the space of Disse flows towards the central vein (A). The lymphatic fluid runs through the perivascular space (represented by green perforated lines) of the central vein and sublobular vein as an extravascular fluid pathway. Secondarily, it enters the interstitium of the vein through the small pores of the cribriform structure of the veins. And then, lymphatic fluid enters the lymphatic vessels of the peripheral portion of the hepatic veins (C). Most of the lymphatic fluid flows through the lymphatic vessels to the inferior vena cava (F). As the hepatic veins become thicker and more centrally located, the lymphatic vessels form a more intimate network of lymphovascular system.

The lymphatic vessels of hepatic veins have been reported to originate from the venous wall of sublobular veins [10, 11] and were found to continue macroscopically to five or six separate lymphatic vessels of the inferior vena cava [3, 17]. However, little information has been provided regarding the continuity and distribution of these lymphatic vessels. Our study revealed that lymphatic vessels are found in the tunica adventitia of sublobular veins with a wall thickness greater than 110 μm. Thus, more lymphatic vessels seem to be present in thinner sublobular veins than suggested by the assessment of cat livers [10]. This may suggest that the lymphatic vessels around the hepatic veins originate from the adventitia of the sublobular veins and develop more densely from the hepatic veins to the inferior vena cava (Fig 7).

In our study, lymphatic vessels were consistently observed from the peripheral and proximal portions to the main trunk of the hepatic vein. Although continuity has previously been reported between lymphatic vessels in sublobular veins, hepatic veins, the inferior vena cava, and the diaphragm [3, 17, 18], most previous observations have been made by macroscopic observation, light microscopy, or electron microscopy of tissue sections. Therefore, it was difficult to evaluate the three-dimensional structure of lymphatic vessels of hepatic veins [19]. The use of whole-mount immunohistochemistry stereomicroscopy of hepatic veins enabled us to evaluate the distribution of lymphatic vessels and their continuity.

The blind ends of the lymphatic vessels in the liver had a button-like appearance, similar to the blind ends of lymphatic vessels observed in other organs [20, 21]. There is a relatively loose arrangement of lymphatic endothelial cells, which plays an important role in the transport of lymphocytes and lymphatic fluid from the connective tissue of the veins into the lymphatic vessels [22, 23]. We found blind ends of the lymphatic vessels in all portions of hepatic veins. This finding suggests that immune cells and interstitial fluid enter the lymphatic vessels through the blind ends.

In this study, the density distribution of lymphatic vessels increased as veins became more centrally located. These results suggest that intrahepatic lymphatic vessels develop in the direction of the blood flow as in hepatic veins. The development of lymphatic vessels contributes to efficient lymphatic fluid transport. There have been no reports on the density of distribution of lymphatic vessels along hepatic veins in humans. Magari et al. reported that perivascular collagen fibrils in rabbit livers increased in proportion from central veins toward sublobular veins [18]. They mentioned that lymphatic flow through collagen fibers depends on blood pressure and permeability. In addition, Ohtani et al. also suggested that collagen fibrils of the hepatic veins functioned as one of the lymphatic fluid pathways [24]. These studies support our assessment of the ratio of lymphatic vessels to vessel area. Lymphatic vessels are thought to allow more efficient lymphatic transport than collagen fibers.

Ohtani et al. examined lymphatic dynamics in the liver using horseradish peroxidase as a tracer and found that HRP injected into the systemic circulation flowed into the periportal lymphatic system [25]. They also showed that the collagen fibrils in the sinusoids continued along with those of central and sublobular veins and functioned as a fluid pathway [2426]. India ink, as used in this study, is a widely used dye for research of lymphatic vessels [27, 28]. After injection into the liver parenchyma, we observed India ink in the perivascular space of central veins and the walls of sublobular veins, whereas in larger sublobular veins, the hepatic vein, and inferior vena cava, the dye was seen in the lymphatic vessels of these walls. The small pores we found in the cribriform structure on the outer wall of the sublobular vein suggested a lymphatic pathway from the perivascular space into the vein wall. These pores were similar in appearance to the milky spots found on the greater omentum that function as a pathway for immune cells and tumor cells to lymphatic vessels [29]. Furthermore, lymphocytes were observed in the meshwork structure consisting of collagen fibrils in the wall of sublobular veins, supporting initial transport through an extravascular pathway in the collagen meshwork structure of the venous wall, before migrating into lymphatic vessels.

Frenkel et al. reported the drainage patterns involving a pathway from the inferior vena cava to mediastinal lymph nodes in the murine livers in vivo [30]. They showed that much of the lymphatic fluid from the middle lobe of the liver flows to the peri-esophageal lymph nodes via the lymphatic vessels around the IVC. They also showed that lymphatic fluid from the right and left lobes of the liver flows to the hilar lymph node. There may be heterogeneity in lymphatic drainage patterns for each region in human liver.

The lymphatic flow pathways were considered as follows: (ⅰ) some of the lymphatics of the space of Disse flow to the perivascular space of the central and sublobular veins. (ⅱ)The lymphatics flow into the collagen fibrils of the veins via the small pores of the vein walls; (ⅲ) they then enter the blind end and flow through the lymphatic vessels.

Patients with hepatic malignancies, such as hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and metastatic liver tumors, are often diagnosed as having mediastinal lymph node metastasis, for which the prognosis is extremely poor [3, 31, 32]. Although the superficial lymphatic system of the liver is generally recognized as the metastatic pathway from the liver to the mediastinal lymph nodes [33, 34], the details have not yet been elucidated. However, it is unlikely that liver tumors deep in the liver metastasize via this pathway. We have identified in this study the hepatic venous lymphatic system may be one of the important pathways. Although further detailed studies are needed, we consider the following lymphatic pathways. One is the pathway the lymphatic vessels around the hepatic vein continuous to IVC to the mediastinum via the diaphragm, and the other is the pathway from the inferior vena cava directly to the mediastinum. Hepatic tumors located deep in the liver may metastasize to mediastinal lymph nodes via these pathways. The hepatic venous lymphovascular system we have described could act as a metastatic pathway in such cases.

This study had the following limitations to be elucidated in the future. First, we investigated a small number of cadavers. However, the aims of this study were to elucidate the anatomical distribution and lymph dynamics in human liver for the first time. Therefore, this study was conducted with a limited sample size. We believe that further experiments with larger sample sizes are needed. Second, lymphatic vessels might have been injured during the whole-mount preparation of hepatic veins. Third, we did not study the entire lymphatic system of the liver. We revealed the lymphatic system around the major hepatic veins in this study. However, we did not reveal the heterogeneity among right, middle, or left hepatic veins. Furthermore, the lymphatic system around caudate lobe was not investigated. Forth, since this study was conducted on cadavers, future studies on lymphodynamics in vivo using Indocyanine green and other techniques are needed.

Conclusions

We revealed the three-dimensional structure and lymphatic dynamics of the hepatic venous lymphatic network in humans. The hepatic venous lymphatic network is one of the most important intrahepatic lymphatic pathways and a clearer understanding may help to elucidate intrahepatic lymphatic physiology and pathologies, such as the spread of malignant disease.

Acknowledgments

The authors thank Drs Yoshiya Asano, Daisuke Okano, Erina Saito, and Kazuto Takahashi for their assistance with generating tissue sections, tissue staining and immunohistochemistry.

Data Availability

All relevant data are within the manuscript.

Funding Statement

The authors received no specific funding for this work.

References

  • 1.Barrowman JA. Hepatic lymph and lymphatics. In: McIntyre N, Benhamou JP, Bircher J, Rizzetto M, eds. Oxford Textbook of Clinical Hepatology. New York: Oxford University Press, 1991:37–40. [Google Scholar]
  • 2.Rouviere H. Lymphatics of the liver, the biliary passages, and the pancreas. In: Tobias MJ, ed. Anatomy of the Human Lymphatic System. Ann Arbor: Edwards Brothers, 1938:197–205. [Google Scholar]
  • 3.Trutmann M, Sasse D. The lymphatics of the liver. Anat Embryol (Berl). 1994;190(3):201–209. doi: 10.1007/BF00234299 [DOI] [PubMed] [Google Scholar]
  • 4.Korita PV, Wakai T, Shirai Y et al. Intrahepatic lymphatic invasion independently predicts poor survival and recurrences after hepatectomy in patients with colorectal carcinoma liver metastases. Ann Surg Oncol. 2007;14(12):3472–3480. doi: 10.1245/s10434-007-9594-2 [DOI] [PubMed] [Google Scholar]
  • 5.Morine Y, Shimada M. The value of systematic lymph node dissection for intrahepatic cholangiocarcinoma from the viewpoint of liver lymphatics. J Gastroenterol. 2015;50(9):913–927. doi: 10.1007/s00535-015-1071-2 [DOI] [PubMed] [Google Scholar]
  • 6.Tanaka M, Iwakiri Y. The Hepatic Lymphatic Vascular System: Structure, Function, Markers, and Lymphangiogenesis. Cell Mol Gastroenterol Hepatol. 2016; 2: 733–749. doi: 10.1016/j.jcmgh.2016.09.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Pupulim LF, Vilgrain V, Ronot M, Becker CD, Breguet R, Terraz S. Hepatic lymphatics: anatomy and related diseases. Abdom Imaging. 2015; 40:1997–2011. doi: 10.1007/s00261-015-0350-y [DOI] [PubMed] [Google Scholar]
  • 8.August DA, Sugarbaker PH, Schneider PD. Lymphatic dissemination of hepatic metastases. Implications for the follow-up and treatment of patients with colorectal cancer. Cancer. 1985; 55:1490–1494. doi: [DOI] [PubMed] [Google Scholar]
  • 9.FP M. A study of the structural unit of the liver. Am J Anat. 1906; 5:227–308. [Google Scholar]
  • 10.Poonkhum R, Pisetpaisan K, Wang BJ, Anupunpisit V, Ohtani Y, Ohtani O. Origins and pathways of fluid entering sublobular lymphatic vessels in cat livers. Arch Histol Cytol. 2003;66(4):317–326. doi: 10.1679/aohc.66.317 [DOI] [PubMed] [Google Scholar]
  • 11.Comparini L. Lymph vessels of the liver in man. J Vasc Res. 1969;6(5):262–274. [DOI] [PubMed] [Google Scholar]
  • 12.Ohtani O. The maceration technique in scanning electron microscopy of collagen fiber frameworks: Its application in the study of human livers. Arch Histol Cytol. 1992;55(Supplement):225–232. [DOI] [PubMed] [Google Scholar]
  • 13.Shimoda H, Kato S, Kudo T. Enzyme-histochemical demonstration of the intramural lymphatic network in the monkey jejunum. Arch Histol Cytol. 1997;60(3):215–224. doi: 10.1679/aohc.60.215 [DOI] [PubMed] [Google Scholar]
  • 14.Shimoda H, Takahashi Y, Kato S. Regrowth of lymphatic vessels following transection of the muscle coat in the rat small intestine. Cell Tissue Res. 2004;316(3):325–338. doi: 10.1007/s00441-004-0889-3 [DOI] [PubMed] [Google Scholar]
  • 15.Xu L, Xue F, Wang B, Yan D, Ding W, Yin J, Yi C, et al. Hoarseness due to lymph node metastasis of hepatocellular carcinoma: A case report. Oncol Lett 2016; 12: 918–920. doi: 10.3892/ol.2016.4687 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Zhu SG, Li HB, Yuan ZN, Liu W, Yang Q, Cheng Y, et al. Achievement of complete response to nivolumab in a patient with advanced sarcomatoid hepatocellular carcinoma: A case report. World J Gastrointest Oncol 2020; 12:1209–1215. doi: 10.4251/wjgo.v12.i10.1209 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Ohtani O, Ohtani Y. Lymph circulation in the liver. Anat Rec (Hoboken). 2008;291:643–652. doi: 10.1002/ar.20681 [DOI] [PubMed] [Google Scholar]
  • 18.Magari S, Nishi A. Form, distribution, fine structure and function of hepatic lymphatics with special reference to blood vessels and bile ducts. Asian Med J. 1980; 24:254–269. [Google Scholar]
  • 19.Nojima S, Susaki EA, Yoshida K et al. Cubic pathology: Three-dimensional imaging for pathological diagnosis. Sci Rep. 2017;7(1):9269. doi: 10.1038/s41598-017-09117-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Yao LC, Baluk P, Srinivasan RS, Oliver G, McDonald DM. Plasticity of button-like junctions in the endothelium of airway lymphatics in development and inflammation. Am J Pathol. 2012;180(6):2561–2575. doi: 10.1016/j.ajpath.2012.02.019 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Zheng W, Nurmi H, Appak S, Sabine A, Bovay E, Korhonen EA, et al. Angiopoietin 2 regulates the transformation and integrity of lymphatic endothelial cell junctions. Genes Dev. 2014;28:1592–1603. doi: 10.1101/gad.237677.114 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Vittet D. Lymphatic collecting vessel maturation and valve morphogenesis. Microvasc Res. 2014;96:31–37. doi: 10.1016/j.mvr.2014.07.001 [DOI] [PubMed] [Google Scholar]
  • 23.Schulte-Merker S, Sabine A, Petrova TV. Lymphatic vascular morphogenesis in development, physiology, and disease. J Cell Biol. 2011;193(4):607–618. doi: 10.1083/jcb.201012094 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Ohtani O. Three-dimensional organization of the collagen fibrillar framework of the human and rat livers. Arch Histol Cytol. 1988;51(5):473–488. doi: 10.1679/aohc.51.473 [DOI] [PubMed] [Google Scholar]
  • 25.Ohtani Y, Wang BJ, Poonkhum R, Ohtani O. Pathways for movement of fluid and cells from hepatic sinusoids to the portal lymphatic vessels and subcapsular region in rat livers. Arch Histol Cytol. 2003;66(3):239–252. doi: 10.1679/aohc.66.239 [DOI] [PubMed] [Google Scholar]
  • 26.Lee FC. On the lymph-vessels of the liver. Carnegie Inst Contrib Embryol. 1923; 15:63–71. [Google Scholar]
  • 27.Clark RR, Shaw-Dunn J, Soutar DS. A cadaveric study of auricular lymphatics and implications for sentinel lymph node biopsy. Clin Anat. 2010;23(7):792–797. doi: 10.1002/ca.21015 [DOI] [PubMed] [Google Scholar]
  • 28.Ohtani Y, Ohtani O. Obliteration of the lymphatic trunks draining diaphragmatic lymph causes peritoneal fluid to enter the pleural cavity. Arch Histol Cytol. 1997;60(5):503–510. doi: 10.1679/aohc.60.503 [DOI] [PubMed] [Google Scholar]
  • 29.Cranshaw ML, Leak LV. Milky spots of the omentum: A source of peritoneal cells in the normal and stimulated animal. Arch Histol Cytol. 1990;53(Supplement):165–177. doi: 10.1679/aohc.53.suppl_165 [DOI] [PubMed] [Google Scholar]
  • 30.Frenkel NC, Poghosyan S, Verheem A, Padera TP, Rinkes I, Kranenburg O, et al. Liver lymphatic drainage patterns follow segmental anatomy in a murine model. Sci Rep 2020; 10:21808. doi: 10.1038/s41598-020-78727-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Seki S, Kitada T, Sakaguchi H et al. Cardiac tamponade caused by spontaneous rupture of mediastinal lymph node metastasis of hepatocellular carcinoma. J Gastroenterol Hepatol. 2001;16(6):702–704. doi: 10.1046/j.1440-1746.2001.02375.x [DOI] [PubMed] [Google Scholar]
  • 32.Tanaka O, Kanematsu M, Kondo H et al. Solitary mediastinal lymph node metastasis of hepatocellular carcinoma: MR imaging findings. Magn Reson Imaging. 2005;23(1):111–114. doi: 10.1016/j.mri.2004.11.001 [DOI] [PubMed] [Google Scholar]
  • 33.Ochiai Y, Kyokane T, Kawai T et al. Liver metastases from rectal cancer with solitary mediastinal lymph node metastasis. Jpn J Gastroenterol Surg. 2017;50(10):796–802. [Google Scholar]
  • 34.Tsukuna M. Anatomy of Lymphatic System in Japanese Population. Tokyo: Kanehara and Co. Ltd., 1968:167. [Google Scholar]

Decision Letter 0

Shozo Yokoyama

27 Mar 2023

PONE-D-23-03219Microanatomical Organization of Hepatic Venous Lymphatic System in HumansPLOS ONE

Dear Dr. Umemura,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by May 11 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Shozo Yokoyama, M.D.,Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified (1) whether consent was informed and (2) what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information.

If you are reporting a retrospective study of medical records or archived samples, please ensure that you have discussed whether all data were fully anonymized before you accessed them and/or whether the IRB or ethics committee waived the requirement for informed consent. If patients provided informed written consent to have data from their medical records used in research, please include this information.

3. Thank you for stating the following in your Competing Interests section:  

"NO authors have competing interests

Enter: The authors have declared that no competing interests exist."

Please complete your Competing Interests on the online submission form to state any Competing Interests. If you have no competing interests, please state "The authors have declared that no competing interests exist.", as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now 

 This information should be included in your cover letter; we will change the online submission form on your behalf.

4. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

Reviewer #3: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Reviewer comments to PONE-D-23-03219

This study researched microanatomical organization of hepatic venous lymphatic system using three female human cadavers. Based on imaging results, the authors demonstrated lymphovascular networks form the central vein to the inferior vena cava.

As the authors mentioned, although the periportal lymphatic system was well discussed so far, the hepatic venous lymphatic system was not fully discussed. In this regard, this study had several novelties.

The reviewer had following comments.

Major comments:

1. In the discussion, the authors discussed about the connection of hepatic venous lymphatic systems to mediastinal lymph nodes. As the authors mentioned, the superficial lymphatic system is a possible pathway but not be elucidated. As for this study, as this study also did not show the connection to the mediastinal lymph nodes microscopically, authors’ discussion may not yet be elucidated.

2. Regarding the distribution of hepatic venous lymphatic systems, was there any heterogeneity among right, middle, or left hepatic veins? How about the hepatic venous lymphatic system in the caudate lobe? The reviewer found an article discussing about the heterogeneity of lymphatic drainage patterns among liver segments, although it was a study using a murine model (Frenkel et al. Sci Rep 2020:10:21808. doi: 10.1038/s41598-020-78727-y.). Please discuss about it.

Minor comments:

1. Please indicate the pathological findings of the liver tissue. Were these cadavers free from any liver disease such as hepatitis or fatty liver?

Reviewer #2: Dear editor I thank you for your invitation to assess the scientific quality of the paper titled: “Microanatomical Organization of Hepatic Venous Lymphatic System in Humans”.

The study reports a very impressive topic, micro-lymphatic vasculature of the liver by using different technique including immunohistochemistry which is very interesting.

The paper in very good in organization and presentation of the data. I kindly request the authors to respond for the following concerns.

1. Why the authors didn’t determine the sample size scientifically? Why only three cadavers were used? Is it possible to conclude on the 3D of hepatic lymphatic vasculature from the data collected from only three cadavers? Could the result be valid?

2. Why only female cadavers were used? Was it not possible to include male in order to compare if sexual dimorphism exist?

3. For how long the cadavers were preserved? What was the preservative used for embalming the cadaver? How the authors check whether the preservative affects the microcirculation of the liver? Since lymphatic wall is very thin.

4. The clinical application of such investigation should be better elaborate at the beginning of the discussion, so that it catches the attention of the readers.

5. In the discussion part, for your finding that states the presence of lymph vessels around thick walled veins than thinned ones, it is good to use development of lymph vessels to explain this.

Reviewer #3: Dr. Umemura and co-authors have written a manuscript on the topic of the anatomical structure of the hepatic venous lymphatic system in humans. The manuscript is well written and provides interesting insights into the lymphatic physiology of the human liver. The authors have conducted a post-mortem study of three human cadavers using both light microscopy, stereomicroscopy and scanning electron microscopy. The main finding is that lymphatic vessels are found in the adventitia of the sublobular veins with a wall thickness greater than 110 μM with an increasingly dense distribution in the proximal trunks of the hepatic veins, creating a rich lymphatic vascular network in the inferior vena cava.

I find the manuscript of good quality, with a clear description of methods and findings, proper use of statistical methods and conclusions that soundly supported by the observations. I only have a few comments that are listed below:

1) I think it would be relevant to elaborate a little on the human cadavers included in the study.

a. Was an informed consent obtained from the relatives of the deceased?

b. What were the causes of death?

c. How long time passed from the time of death to the specimen collection?

2) Did the authors observe any anatomical differences between the different subjects – e.g., with regards to the distribution density of lymphatic vessels? Would it be possible to plot the observations from the individual subjects with difference symbols/colours in the plots?

3) A minor point: I would suggest moving the section on statistics to the end of the methods section.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Melese Shenkut Abebe

Reviewer #3: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2023 May 25;18(5):e0286316. doi: 10.1371/journal.pone.0286316.r002

Author response to Decision Letter 0


4 May 2023

Reviewer #1

In the discussion, the authors discussed about the connection of hepatic venous lymphatic systems to mediastinal lymph nodes. As the authors mentioned, the superficial lymphatic system is a possible pathway but not be elucidated. As for this study, as this study also did not show the connection to the mediastinal lymph nodes microscopically, authors’ discussion may not yet be elucidated

Reply)

We thank you for your suggestion. Per your remark, our study is not elucidated on that point. The superficial lymphatic system was reported as the metastatic pathway from the liver to the mediastinum (33,34). However, it is unlikely that liver tumors deep in the liver metastasize via this pathway. We have identified in this study the hepatic venous lymphatic system may be one of the important pathways. Although further detailed studies are needed, we assume the following lymphatic pathways. One is the pathway the lymphatic vessels around the hepatic vein continuous to IVC to the mediastinum via the diaphragm, and the other is the pathway from the inferior vena cava directly to the mediastinum. We have added the following text to the Discussion.

However, it is unlikely that liver tumors deep in the liver metastasize via this pathway. We have identified in this study the hepatic venous lymphatic system may be one of the important pathways. Although further detailed studies are needed, we consider the following lymphatic pathways. One is the pathway the lymphatic vessels around the hepatic vein continuous to IVC to the mediastinum via the diaphragm, and the other is the pathway from the inferior vena cava directly to the mediastinum. Hepatic tumors located deep in the liver may metastasize to mediastinal lymph nodes via these pathways. Page 17, 379-386

Regarding the distribution of hepatic venous lymphatic systems, was there any heterogeneity among right, middle, or left hepatic veins? How about the hepatic venous lymphatic system in the caudate lobe? The reviewer found an article discussing about the heterogeneity of lymphatic drainage patterns among liver segments, although it was a study using a murine model (Frenkel et al. Sci Rep 2020:10:21808. doi: 10.1038/s41598-020-78727-y.). Please discuss about it.

Reply)

Thank you for your suggestion. In the literature you taught us, Frenkel et al. reported lymphatic drainage patterns in the murine liver in vivo. They included results similar to and different from ours. Although we studied the correlation between the diameters of hepatic veins and lymphatic vessel distribution, we did not elucidate differences in the distribution rate of lymphatic vessels in the right, middle, and left hepatic veins. We also did not examine the distribution rate of lymphatic vessels around the caudate lobe. We have cited their report in the paper because it was extremely important. Additionally, we added the following text to the Discussion.

1.Frenkel et al. reported the drainage patterns involving a pathway from the inferior vena cava to mediastinal lymph nodes in the murine livers in vivo (28). They showed that much of the lymphatic fluid from the middle lobe of the liver flows to the peri-esophageal lymph nodes via the lymphatic vessels around the IVC. They also showed that lymphatic fluid from the right and left lobes of the liver flows to the hilar lymph node. There may be heterogeneity in lymphatic drainage patterns for each region in human liver. Page 16, 362-368

2. Third, we did not study the entire lymphatic system of the liver. We revealed the lymphatic system around the major hepatic veins in this study. However, we did not reveal the heterogeneity among right, middle, or left hepatic veins. Furthermore, the lymphatic system around caudate lobe was not investigated. Page 18 393-397

1. Please indicate the pathological findings of the liver tissue. Were these cadavers free from any liver disease such as hepatitis or fatty liver?

Reply)

We appreciate your remark. The pathological findings of the liver for each cadaver were as follows.

The pathological findings of Cadaver 1 showed mild hepatitis with mild inflammatory cell infiltration in the portal area, but no liver fibrosis or fatty liver.

The pathological findings of Cadaver 2 showed moderate hepatitis with fibrotic enlargement and moderate inflammatory cell infiltration in the portal area, but no fatty liver. The pathological findings on cadaver 3 did not show any liver disease, including fibrosis or hepatitis. Table 1 was added as details of the cadavers.s

Reviewer #2:

1. Why the authors didn’t determine the sample size scientifically? Why only three cadavers were used? Is it possible to conclude on the 3D of hepatic lymphatic vasculature from the data collected from only three cadavers? Could the result be valid?

Reply)

We appreciate your remarks. We conducted this study on three cadavers. The main studies on the three cadavers were as follows. Cadaver No.1: Sections across the hepatic veins and inferior vena cava were prepared and studied to clarify the lymphatic anatomy around the hepatic veins, including the sublobular vein. Cadaver No.2: To elucidate the lymph dynamics around the hepatic veins, sections were prepared from liver specimens in which Indian ink was injected into the right lobe and examined using microscope. Cadaver No.3: To clarify the three-dimensional structure and distribution of lymphatic vessels around hepatic veins, whole mount immunostaining was performed on a block of hepatic vein with the liver parenchyma removed and examined using stereomicroscope. We added to Table 1 as the details of cadavers including the purpose of the experiment.

Per your remark, the sample size was very small in this study. However, the aims of this study were to elucidate the anatomical distribution and lymph dynamics in human liver for the first time. Therefore, this study was conducted with a limited sample size. We believe that further experiments with larger sample sizes are needed. We added the following text to the Discussion.

First, we investigated a small number of cadavers. The sample size was very small in this study. However, the aims of this study were to elucidate the anatomical distribution and lymph dynamics in human liver for the first time. Therefore, this study was conducted with a limited sample size. We believe that further experiments with larger sample sizes are needed. Page 18, 388-392

2. Why only female cadavers were used? Was it not possible to include male in order to compare if sexual dimorphism exist?

Reply)

We appreciate your remark. I checked the gender of the three cadavers again. As a result, cadaver 1 was male, not female. We added Table1 to the Materials and Methods.

Page 5,6 97-109

3. For how long the cadavers were preserved? What was the preservative used for embalming the cadaver? How the authors check whether the preservative affects the microcirculation of the liver? Since lymphatic wall is very thin.

Reply)

We appreciate your remark. Preservation time were listed in Table 1. Postmortem, 10% formalin and 5% phenol were injected through the femoral artery of the cadavers and fixed for at least 1 week. After fixation, it was replaced with 60% alcohol + 5% phenol. Per your remark, Lymphatic vessels were observed collapsed in the 5 μm sections. However, the presence or absence of lymphatic vessels was not considered to be affected. We think further studies on microcirculation using ICG and other dyes in vivo are needed. We added the following text to the Materials and Methods and the Discussion.

Postmortem, 10% formalin and 5% phenol were injected through the femoral artery of the cadavers and fixed. They had no hepatic tumors or abdominal malformations. The details of the cadavers used in the experiment were shown in Table 1. Page5, 6 97-109

Forth, since this study was conducted on cadavers, future studies on lymphodynamics in vivo using ICG and other techniques are needed. Page 18 397-399

4. The clinical application of such investigation should be better elaborate at the beginning of the discussion, so that it catches the attention of the readers.

Reply) Thank you for your suggestion. Per your remark, we added the following text at the beginning of the Discussion.

Liver tumors, including metastatic liver tumors and primary liver cancer, are known to metastasize to mediastinal lymph nodes. The prognosis for patients with mediastinal lymph node metastases is extremely poor, and little is known about the pathway of metastasis. (17,18) Therefore, clarification of intrahepatic lymphatic anatomy is needed to elucidate the pathway of metastasis. We focused on the lymphatic anatomy around the hepatic veins. Page 13, 14, 291-296

5. In the discussion part, for your finding that states the presence of lymph vessels around thick walled veins than thinned ones, it is good to use development of lymph vessels to explain this.

Reply)

We appreciate your remark. We added the following sentence in discussion.

This may suggest that the lymphatic vessels around the hepatic veins originate from the adventitia of the sublobular veins and develop more densely from the hepatic veins to the inferior vena cava (Fig 7). Page 14, 314-316

Reviewer #3

1) I think it would be relevant to elaborate a little on the human cadavers included in the study.

a. Was an informed consent obtained from the relatives of the deceased?

Reply)

Thank you for your suggestion. We obtained consent from the individuals and their relatives before their death to be a specimen. The donors have been enrolled before their death in an association of people who have offered to donate their bodies with the consent of themselves and their relatives, provided that they are not infected with human immunodeficiency virus, hepatitis B virus, or hepatitis C virus. Additionally, we received opt-out consent from the relatives for this study. We added the following text to the Materials and Methods.

The donors were enrolled before their death in an association of people who had offered to donate their bodies with the consent of themselves and their relatives, provided that they were not infected with human immunodeficiency virus, hepatitis B virus, or hepatitis C virus. Additionally, we received opt-out consent from the relatives for this study. Page5 88-93, 95

b. What were the causes of death?

Reply) Thank you for your remark. We added the details of the cadavers, including cause of death, in Table 1.

c. How long time passed from the time of death to the specimen collection?

Reply) Thank you for your remark. We added the details of the cadavers, including the time before specimen collection, in Table 1.

2) Did the authors observe any anatomical differences between the different subjects – e.g., with regards to the distribution density of lymphatic vessels? Would it be possible to plot the observations from the individual subjects with difference symbols/colours in the plots?

Reply) We appreciate your remarks. Unfortunately, only one cadaver (No.3) was measured and used as statistical data in this study, so it is not possible to show differences among the individuals. It is necessary to increase the number of cadavers and examine anatomical differences in the future. We added the following text to the Results and the Discussion.

Microscopically, dense lymphatic vessels were observed in the more central part of the hepatic veins. Therefore, we examined the relationship between the diameter of hepatic veins and the density of lymphatic vessels. Page11 234-236

However, the aims of this study were to elucidate the anatomical distribution and lymph dynamics in human liver for the first time. Therefore, this study was conducted with a limited sample size. We believe that further experiments with larger sample sizes are needed. Page18 389-392

3) A minor point: I would suggest moving the section on statistics to the end of the methods section.

Reply)

We appreciate your remark. We have made the changes as you indicated. Page 9, 10 186-195

Attachment

Submitted filename: Response to reviewer.docx

Decision Letter 1

Shozo Yokoyama

15 May 2023

Microanatomical Organization of Hepatic Venous Lymphatic System in  Humans

PONE-D-23-03219R1

Dear Dr. Umemura,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Shozo Yokoyama, M.D.,Ph.D.

Academic Editor

PLOS ONE

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

Reviewer #3: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

Reviewer #2: I would like to thank the authors.

They responded for all my comments and I am happy with that.

Best of luck.

Reviewer #3: No further comments

(..............................................................................)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

**********

Acceptance letter

Shozo Yokoyama

17 May 2023

PONE-D-23-03219R1

Microanatomical Organization of Hepatic Venous Lymphatic System in  Humans

Dear Dr. Umemura:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Shozo Yokoyama

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: Response to reviewer.docx

    Data Availability Statement

    All relevant data are within the manuscript.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES